speb/financial-data huggingface dataset:
Financial ratios for CBFV — annual report dated 2023-12-31
Total revenue: 42361000
Net income: 22550000
Capital expenditures: 3246000
Operating cash flow: 14236000
Depreciation & amortization: 2737000
Net tangible assets: 129144000
Owner earnings: 22041000
Return on net tangible assets (%): 17.06699498234529
Buffett classification: The Gruesome
Stock price: 21.77
P/E ratio: 4.897150397782705
Shares outstanding: 5072611
Book value: 139834000
P/B ratio: 0.7897274015618518
Market cap (USD): 110430741.47
Debt to equity: 0.24799405008796144
Effective tax rate (%): 25.540696714545152
COGS to revenue (%): 0
SG&A to revenue (%): 55.260735110124884
Free cash flow (dilution-adjusted): 9818000
Buyback yield (%): 0.7633743908429812
Retained earnings: 83392000
Capitalized R&D asset: 0
FCF margin (%): 23.17697882486249
Revenue growth (%): -15.216956208470098
Rule of 40 score: 7.9600226163923935
Financial ratios for CBFV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.42
Shares outstanding: 5072611
Market cap (USD): 134018382.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBFV — annual report dated 2024-12-31
Total revenue: 49138000
Net income: 12594000
Capital expenditures: 2327000
Operating cash flow: 6750000
Depreciation & amortization: 2425000
Net tangible assets: 137646000
Owner earnings: 12692000
Return on net tangible assets (%): 9.220754689565988
Buffett classification: The Gruesome
Stock price: 27.24
P/E ratio: 10.971726507860884
Shares outstanding: 5072611
Book value: 147378000
P/B ratio: 0.937574968041363
Market cap (USD): 138177923.64
Debt to equity: 0.2355711164488594
Effective tax rate (%): 17.916965391383695
COGS to revenue (%): 0
SG&A to revenue (%): 41.265415767837524
Free cash flow (dilution-adjusted): 2623000
Buyback yield (%): 0.6983749462860289
Retained earnings: 90856000
Capitalized R&D asset: 0
FCF margin (%): 5.338027595750742
Revenue growth (%): 15.9982058969335
Rule of 40 score: 21.336233492684244
Financial ratios for CBFV — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 88000
Buffett classification: The Gruesome
Stock price: 27.24
Shares outstanding: 5072611
Market cap (USD): 138177923.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBFV — quarterly report dated 2025-03-31
Total revenue: 11788000
Net income: 1909000
Capital expenditures: 101000
Operating cash flow: 4027000
Depreciation & amortization: 442000
Net tangible assets: 138557000
Owner earnings: 2250000
Return on net tangible assets (%): 1.623880424662774
Buffett classification: The Gruesome
Stock price: 27.34
P/E ratio: 18.162020002619172
Shares outstanding: 5072611
Book value: 148289000
P/B ratio: 0.935235821537673
Market cap (USD): 138685184.74
Debt to equity: 0.23419134258104107
Effective tax rate (%): 18.279109589041095
COGS to revenue (%): 0
SG&A to revenue (%): 53.707159823549375
Free cash flow (dilution-adjusted): 3703000
Buyback yield (%): 1.714674861960313
Retained earnings: 91484000
Capitalized R&D asset: 0
FCF margin (%): 31.413301662707838
Rule of 40 score: 31.413301662707838
Financial ratios for CBFV — quarterly report dated 2025-06-30
Total revenue: 13089000
Net income: 3949000
Capital expenditures: 257000
Operating cash flow: 4132000
Depreciation & amortization: 452000
Net tangible assets: 138630000
Owner earnings: 4144000
Return on net tangible assets (%): 2.989251965663998
Buffett classification: The Gruesome
Stock price: 27.62
P/E ratio: 23.916953878456813
Shares outstanding: 5072611
Book value: 148362000
P/B ratio: 0.9443490639112442
Market cap (USD): 140105515.82
Debt to equity: 0.23414351383777518
Effective tax rate (%): 16.246023329798515
COGS to revenue (%): 0
SG&A to revenue (%): 41.370616548246616
Free cash flow (dilution-adjusted): 3682000
Buyback yield (%): 3.1697538630138995
Retained earnings: 94178000
Capitalized R&D asset: 0
FCF margin (%): 28.1304912521965
Revenue growth (%): 11.036647438072617
Rule of 40 score: 39.16713869026911
Financial ratios for CBFV — quarterly report dated 2025-09-30
Total revenue: 2051000
Net income: -5696000
Capital expenditures: 104000
Operating cash flow: 4621000
Depreciation & amortization: 455000
Net tangible assets: 142733000
Owner earnings: -5345000
Return on net tangible assets (%): -3.74475419139232
Buffett classification: The Gruesome
Stock price: 32.45
P/E ratio: 1016.0878206790125
Shares outstanding: 5072611
Book value: 152465000
P/B ratio: 1.079632879349359
Market cap (USD): 164606226.95000002
Debt to equity: 0.22790804446922244
COGS to revenue (%): 0
SG&A to revenue (%): 270.69722086786936
Free cash flow (dilution-adjusted): 4323000
Buyback yield (%): 0.004252573022116767
Retained earnings: 87188000
Capitalized R&D asset: 0
FCF margin (%): 210.7752315943442
Revenue growth (%): -84.33035373214149
Rule of 40 score: 126.44487786220272
Financial ratios for CBFV — quarterly report dated 2025-12-31
Total revenue: 14570000
Net income: 4739000
Capital expenditures: 147000
Operating cash flow: 5027000
Depreciation & amortization: 461000
Net tangible assets: 147805000
Owner earnings: 5053000
Return on net tangible assets (%): 3.4186935489327155
Buffett classification: The Gruesome
Stock price: 34.32
P/E ratio: 35.52173220159151
Shares outstanding: 5072611
Book value: 157537000
P/B ratio: 1.1050864845718784
Market cap (USD): 174092009.52
Debt to equity: 0.22063388283387395
Effective tax rate (%): 10.024681982153028
COGS to revenue (%): 0
SG&A to revenue (%): 44.45435827041867
Free cash flow (dilution-adjusted): 4653000
Buyback yield (%): 0.008041724625156708
Retained earnings: 90625000
Capitalized R&D asset: 0
FCF margin (%): 31.93548387096774
Revenue growth (%): 610.3851779619697
Rule of 40 score: 642.3206618329374
Financial ratios for CBFV — annual report dated 2025-12-31
Total revenue: 41498000
Net income: 4903000
Capital expenditures: 609000
Operating cash flow: 17807000
Depreciation & amortization: 1810000
Net tangible assets: 147805000
Owner earnings: 6104000
Return on net tangible assets (%): 4.129765569500355
Buffett classification: The Gruesome
Stock price: 34.32
P/E ratio: 35.507242406689784
Shares outstanding: 5072611
Book value: 157537000
P/B ratio: 1.1050864845718784
Market cap (USD): 174092009.52
Debt to equity: 0.22063388283387395
Effective tax rate (%): 7.490566037735849
COGS to revenue (%): 0
SG&A to revenue (%): 57.28950792809292
Free cash flow (dilution-adjusted): 16361000
Buyback yield (%): 3.9289568882908488
Retained earnings: 90625000
Capitalized R&D asset: 0
FCF margin (%): 39.425996433563064
Revenue growth (%): -15.548048353616345
Rule of 40 score: 23.87794807994672
Financial ratios for CSC.L — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 302702.7027027027
Buffett classification: The Gruesome
Stock price: 0.010135135135135136
Shares outstanding: 38667163
Market cap (USD): 391896.92229729734
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.L — annual report dated 2022-09-30
Total revenue: 27710000
Gross profit: 5843333.333333333
Operating income: -3027777.7777777775
Net income: -4485555.555555555
Capital expenditures: 1696666.6666666665
Operating cash flow: 738888.8888888889
Depreciation & amortization: 1864444.4444444445
Net tangible assets: 13447777.777777778
Owner earnings: -4317777.777777777
Return on net tangible assets (%): -32.10774188217796
Buffett classification: The Gruesome
Stock price: 0.0028888888888888888
Shares outstanding: 38667163
Book value: 13447777.777777776
P/B ratio: 0.008306587110633729
Market cap (USD): 111705.13755555556
Debt to equity: 0.4365033462777824
Current ratio: 1.2369724121669419
Quick ratio: 0.878094788964867
Interest coverage ratio: -9.332191780821917
COGS to revenue (%): 78.91254661373752
SG&A to revenue (%): 31.609126268094144
Free cash flow (dilution-adjusted): 7777.777777777781
Buyback yield (%): 0
Retained earnings: 12016666.666666666
Inventory turnover: 4.31011826544021
Receivables turnover: 5.4297844546048335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.319327731092436
FCF margin (%): 0.028068487108544864
Rule of 40 score: 0.028068487108544864
Financial ratios for CSC.L — annual report dated 2023-09-30
Total revenue: 25203658.53658537
Gross profit: 8541463.414634148
Operating income: 1439024.3902439026
Net income: -828048.7804878049
Capital expenditures: 485365.8536585366
Operating cash flow: -36585.365853658535
Depreciation & amortization: 1008536.5853658537
Net tangible assets: 16568292.68292683
Owner earnings: -304878.0487804878
Return on net tangible assets (%): -1.8401295451199764
Capex to operating income (%): 33.728813559322035
Buffett classification: The Good
Stock price: 0.003658536585365854
Shares outstanding: 38667163
Book value: 16568292.682926828
P/B ratio: 0.008538310687472399
Market cap (USD): 141465.2304878049
Debt to equity: 0.24348594141027533
Current ratio: 1.4599268069533393
Quick ratio: 0.9503202195791399
Interest coverage ratio: 4.486692015209125
COGS to revenue (%): 66.1102240286447
SG&A to revenue (%): 28.180190642086416
Free cash flow (dilution-adjusted): -795121.9512195123
Buyback yield (%): 0
Retained earnings: 12447560.975609757
Inventory turnover: 2.4529622980251347
Receivables turnover: 3.2181563375895363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.3685525165480215
FCF margin (%): -3.1547878260028064
Revenue growth (%): -9.04489882141693
Rule of 40 score: -12.199686647419737
Financial ratios for CSC.L — annual report dated 2024-09-30
Total revenue: 19769333.333333332
Gross profit: 6517333.333333333
Operating income: -2229333.3333333335
Net income: -3249333.3333333335
Capital expenditures: 561333.3333333334
Operating cash flow: 840000
Depreciation & amortization: 1002666.6666666666
Net tangible assets: 14881333.333333334
Owner earnings: -2808000.0000000005
Return on net tangible assets (%): -18.869276946510173
Buffett classification: The Gruesome
Stock price: 0.0044
Shares outstanding: 38667163
Book value: 14881333.333333336
P/B ratio: 0.01143281407579966
Market cap (USD): 170135.5172
Debt to equity: 0.1395932264134038
Current ratio: 1.3824272008079448
Quick ratio: 1.1282612354822419
Interest coverage ratio: -6.0361010830324915
COGS to revenue (%): 67.03311526269644
SG&A to revenue (%): 44.24360963107844
Free cash flow (dilution-adjusted): 234666.6666666667
Buyback yield (%): 0
Retained earnings: 10390666.666666666
Inventory turnover: 3.291059602649007
Receivables turnover: 6.0395112016293275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.330144303595631
FCF margin (%): 1.1870236730289339
Revenue growth (%): -21.561652231415636
Rule of 40 score: -20.374628558386704
Financial ratios for CSC.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 14881333.333333334
Buffett classification: The Gruesome
Stock price: 0.0044
Shares outstanding: 38667163
Book value: 14881333.333333336
P/B ratio: 0.01143281407579966
Market cap (USD): 170135.5172
Debt to equity: 0.1395932264134038
Current ratio: 1.3824272008079448
Quick ratio: 1.1282612354822419
Buyback yield (%): 0
Retained earnings: 10390666.666666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 11625974.025974026
Buffett classification: The Gruesome
Stock price: 0.004285714285714286
Shares outstanding: 38667163
Book value: 11625974.025974028
P/B ratio: 0.014253980998659516
Market cap (USD): 165716.41285714286
Debt to equity: 0.048592493297587115
Current ratio: 1.449936628643853
Quick ratio: 0.9612529422415356
Buyback yield (%): 0
Retained earnings: 7255844.155844156
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 14616216.216216216
Buffett classification: The Gruesome
Stock price: 0.004324324324324324
Shares outstanding: 38667163
Book value: 14616216.216216216
P/B ratio: 0.011439989053254438
Market cap (USD): 167209.35351351352
Debt to equity: 0.0334689349112426
Current ratio: 1.8063386447207144
Quick ratio: 1.347925056907722
Buyback yield (%): 0
Retained earnings: 10062162.162162162
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSC.L — annual report dated 2025-09-30
Total revenue: 22409459.45945946
Gross profit: 8629729.72972973
Operating income: 58108.10810810811
Net income: -478378.3783783784
Capital expenditures: 408108.1081081081
Operating cash flow: -791891.891891892
Depreciation & amortization: 1091891.8918918918
Net tangible assets: 14616216.216216216
Owner earnings: 205405.40540540527
Capex to operating income (%): 702.3255813953489
Buffett classification: The Gruesome
Stock price: 0.004324324324324324
Shares outstanding: 38667163
Book value: 14616216.216216216
P/B ratio: 0.011439989053254438
Market cap (USD): 167209.35351351352
Debt to equity: 0.0334689349112426
Current ratio: 1.8063386447207144
Quick ratio: 1.347925056907722
Interest coverage ratio: 0.6935483870967741
COGS to revenue (%): 61.490683229813655
SG&A to revenue (%): 38.25001507567991
Free cash flow (dilution-adjusted): -1209459.4594594594
Buyback yield (%): 0
Retained earnings: 10062162.162162162
Inventory turnover: 3.8949579831932772
Receivables turnover: 4.339963360376864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.364715860899067
FCF margin (%): -5.397093408912741
Revenue growth (%): 13.354654310343273
Rule of 40 score: 7.957560901430532
Financial ratios for CTOS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 227432821
Market cap (USD): 1819462568
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTOS — annual report dated 2022-12-31
Total revenue: 1573086000
Gross profit: 383748000
Operating income: 129526000
Net income: 38905000
Capital expenditures: 134939000
Operating cash flow: 45968000
Depreciation & amortization: 223483000
Net tangible assets: -119516000
Owner earnings: 127449000
Return on net tangible assets (%): -106.63760500686101
Capex to operating income (%): 104.17908373608387
Buffett classification: The Gruesome
Stock price: 6.32
P/E ratio: 36.945776345456885
Shares outstanding: 227432821
Book value: 888443000
P/B ratio: 1.6178589157886325
Market cap (USD): 1437375428.72
Debt to equity: 2.0563592712194256
Current ratio: 1.3675777078430817
Quick ratio: 0.42767429332879703
Effective tax rate (%): 16.74869468458444
Interest coverage ratio: 1.4568870492430208
COGS to revenue (%): 75.60540237469534
SG&A to revenue (%): 13.404734388329691
Free cash flow (dilution-adjusted): -307120000
Buyback yield (%): 0.7151228408818406
Retained earnings: -608585000
Inventory turnover: 1.993112393669435
Receivables turnover: 6.798800226470219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.623413712470706
FCF margin (%): -19.523408128989768
Rule of 40 score: -19.523408128989768
Financial ratios for CTOS — annual report dated 2023-12-31
Total revenue: 1865100000
Gross profit: 454260000
Operating income: 185091000
Net income: 50712000
Capital expenditures: 134631000
Operating cash flow: -30883000
Depreciation & amortization: 218993000
Net tangible assets: -64020000
Owner earnings: 135074000
Return on net tangible assets (%): -210.9871915026554
Capex to operating income (%): 72.7377344117218
Buffett classification: The Good
Stock price: 6.18
P/E ratio: 27.716020543066726
Shares outstanding: 227432821
Book value: 917203000
P/B ratio: 1.5324141261858062
Market cap (USD): 1405534833.78
Debt to equity: 2.3953050742311137
Current ratio: 1.4106468878045084
Quick ratio: 0.31213331119503357
Effective tax rate (%): 12.67993663475446
Interest coverage ratio: 1.4095190953051822
COGS to revenue (%): 75.64420138330384
SG&A to revenue (%): 12.407002305506406
Free cash flow (dilution-adjusted): -408382000
Buyback yield (%): 2.763716634153528
Retained earnings: -557873000
Inventory turnover: 1.4311712183275613
Receivables turnover: 7.583741979555491
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.492325154387454
FCF margin (%): -21.89598412953729
Revenue growth (%): 18.56313005137672
Rule of 40 score: -3.332854078160569
Financial ratios for CTOS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.45
Shares outstanding: 227432821
Market cap (USD): 784643232.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTOS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.81
Shares outstanding: 227432821
Market cap (USD): 1093951869.01
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTOS — annual report dated 2024-12-31
Total revenue: 1802280000
Gross profit: 390270000
Operating income: 120781000
Net income: -28655000
Capital expenditures: 141193000
Operating cash flow: 121985000
Depreciation & amortization: 235839000
Net tangible assets: -95890000
Owner earnings: 65991000
Capex to operating income (%): 116.9000091073927
Buffett classification: The Gruesome
Stock price: 4.81
Shares outstanding: 227432821
Book value: 861309000
P/B ratio: 1.2701038407934897
Market cap (USD): 1093951869.01
Debt to equity: 2.8156805513468455
Current ratio: 1.3005403212348143
Quick ratio: 0.25197136807098225
Interest coverage ratio: 0.722785075252087
COGS to revenue (%): 78.34576203475598
SG&A to revenue (%): 12.73631178285283
Free cash flow (dilution-adjusted): -288191000
Buyback yield (%): 2.649476711094229
Retained earnings: -586528000
Inventory turnover: 1.3456634111754078
Receivables turnover: 8.017759113112026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.8287946983647485
FCF margin (%): -15.990356659342611
Revenue growth (%): -3.3681840115811483
Rule of 40 score: -19.35854067092376
Financial ratios for CTOS — quarterly report dated 2025-03-31
Total revenue: 422232000
Gross profit: 85536000
Operating income: 16065000
Net income: -17791000
Capital expenditures: 67386000
Operating cash flow: 55635000
Depreciation & amortization: 62137000
Net tangible assets: -137095000
Owner earnings: -23040000
Capex to operating income (%): 419.45845004668536
Buffett classification: The Gruesome
Stock price: 4.22
Shares outstanding: 227432821
Book value: 813419000
P/B ratio: 1.1799165062778223
Market cap (USD): 959766504.6199999
Debt to equity: 3.049932445639947
Current ratio: 1.289110774605053
Quick ratio: 0.23894338399474346
Interest coverage ratio: 0.41284403669724773
COGS to revenue (%): 79.74194281816631
SG&A to revenue (%): 14.080173932814189
Free cash flow (dilution-adjusted): -58702000
Buyback yield (%): 3.3940546834250496
Retained earnings: -604319000
Inventory turnover: 0.3130206808071511
Receivables turnover: 2.008782404742308
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6378399281839489
FCF margin (%): -13.902783303965593
Rule of 40 score: -13.902783303965593
Financial ratios for CTOS — quarterly report dated 2025-06-30
Total revenue: 511483000
Gross profit: 102542000
Operating income: 33234000
Net income: -28380000
Capital expenditures: 63946000
Operating cash flow: 125718000
Depreciation & amortization: 66031000
Net tangible assets: -154254000
Owner earnings: -26295000
Capex to operating income (%): 192.41138593007162
Buffett classification: The Gruesome
Stock price: 4.94
Shares outstanding: 227432821
Book value: 790127000
P/B ratio: 1.42194626400566
Market cap (USD): 1123518135.74
Debt to equity: 3.176050179274977
Current ratio: 1.2560067570118154
Quick ratio: 0.22806802310218566
Interest coverage ratio: 0.8266341657546513
COGS to revenue (%): 79.95202186582937
SG&A to revenue (%): 11.567344369216572
Free cash flow (dilution-adjusted): 10577000
Buyback yield (%): 0
Retained earnings: -632699000
Inventory turnover: 0.37543527856451026
Receivables turnover: 2.598629260064625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3202324409959305
FCF margin (%): 2.0679084153334517
Revenue growth (%): 21.13790522745789
Rule of 40 score: 23.20581364279134
Financial ratios for CTOS — quarterly report dated 2025-09-30
Total revenue: 482058000
Gross profit: 100753000
Operating income: 35875000
Net income: -5756000
Capital expenditures: 78842000
Operating cash flow: 81451000
Depreciation & amortization: 66842000
Net tangible assets: -152700000
Owner earnings: -17756000
Capex to operating income (%): 219.7686411149826
Buffett classification: The Gruesome
Stock price: 6.42
Shares outstanding: 227432821
Book value: 784682000
P/B ratio: 1.8607776281601973
Market cap (USD): 1460118710.82
Debt to equity: 3.174926913067969
Current ratio: 1.2708518402858837
Quick ratio: 0.22421280393090198
Interest coverage ratio: 0.891370785400154
COGS to revenue (%): 79.09940297640533
SG&A to revenue (%): 11.38099564782661
Free cash flow (dilution-adjusted): -44253000
Buyback yield (%): 0
Retained earnings: -638455000
Inventory turnover: 0.36818224830588175
Receivables turnover: 2.5500317393144307
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.406193286803851
FCF margin (%): -9.180015682760166
Revenue growth (%): -5.752879372334956
Rule of 40 score: -14.932895055095122
Financial ratios for CTOS — annual report dated 2025-12-31
Total revenue: 1943957000
Gross profit: 411892000
Operating income: 141582000
Net income: -31052000
Capital expenditures: 250903000
Operating cash flow: 310112000
Depreciation & amortization: 263880000
Net tangible assets: -121789000
Owner earnings: -18075000
Capex to operating income (%): 177.21391137291465
Buffett classification: The Gruesome
Stock price: 5.76
Shares outstanding: 227432821
Book value: 809103000
P/B ratio: 1.619093056088038
Market cap (USD): 1310013048.96
Debt to equity: 2.987872990212618
Current ratio: 1.3266634605475593
Quick ratio: 0.2606987049568891
Interest coverage ratio: 0.8982546520406803
COGS to revenue (%): 78.8116712458146
SG&A to revenue (%): 11.835755626281857
Free cash flow (dilution-adjusted): -155343000
Buyback yield (%): 2.4866164520926577
Retained earnings: -617580000
Inventory turnover: 1.6457200740327778
Receivables turnover: 9.510832020509408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.513051550470304
FCF margin (%): -7.991071818975421
Revenue growth (%): 7.860987193998713
Rule of 40 score: -0.1300846249767078
Financial ratios for CTOS — quarterly report dated 2025-12-31
Total revenue: 528184000
Gross profit: 123061000
Operating income: 56408000
Net income: 20875000
Capital expenditures: 40729000
Operating cash flow: 47308000
Depreciation & amortization: 68870000
Net tangible assets: -121789000
Owner earnings: 49016000
Return on net tangible assets (%): -40.24665610194681
Capex to operating income (%): 72.2042972627996
Buffett classification: The Good
Stock price: 5.76
P/E ratio: 15.688779029461076
Shares outstanding: 227432821
Book value: 809103000
P/B ratio: 1.619093056088038
Market cap (USD): 1310013048.96
Debt to equity: 2.987872990212618
Current ratio: 1.3266634605475593
Quick ratio: 0.2606987049568891
Effective tax rate (%): -39.092484008528785
Interest coverage ratio: 1.474526205724742
COGS to revenue (%): 76.70111173378974
SG&A to revenue (%): 10.716530602971691
Free cash flow (dilution-adjusted): -62965000
Buyback yield (%): 0
Retained earnings: -617580000
Inventory turnover: 0.4351767409035393
Receivables turnover: 2.5841463056645497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1964671487825354
FCF margin (%): -11.921035093830938
Revenue growth (%): 9.568558140306768
Rule of 40 score: -2.352476953524169
Financial ratios for CURB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.11
Shares outstanding: 114037648
Market cap (USD): 2635410045.2799997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURB — annual report dated 2024-12-31
Total revenue: 120881000
Gross profit: 93278000
Operating income: 33928000
Net income: 10273000
Capital expenditures: 0
Operating cash flow: 54260000
Depreciation & amortization: 41911000
Net tangible assets: 1859114000
Owner earnings: 52184000
Return on net tangible assets (%): 2.8069284616220416
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.28
P/E ratio: 247.3239362834615
Shares outstanding: 114037648
Book value: 1942557000
P/B ratio: 1.3079455570364218
Market cap (USD): 2540758797.44
Debt to equity: 0.020668119391091228
Current ratio: 13.630973170344499
Quick ratio: 13.630973170344499
Effective tax rate (%): 0.038921864357302716
Interest coverage ratio: 37.65593784683685
COGS to revenue (%): 22.83485411272243
SG&A to revenue (%): 14.426584823090478
Free cash flow (dilution-adjusted): 50435000
Buyback yield (%): 0.0009052413799835773
Retained earnings: -15021000
Receivables turnover: 2.3768802721355957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.711196718020725
FCF margin (%): 41.722851399310066
Revenue growth (%): 29.063634422378815
Rule of 40 score: 70.78648582168888
Financial ratios for CURB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.28
Shares outstanding: 114037648
Market cap (USD): 2540758797.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CURB — quarterly report dated 2025-03-31
Total revenue: 38695000
Gross profit: 28472000
Operating income: 5081000
Net income: 10562000
Capital expenditures: 0
Operating cash flow: 25371000
Depreciation & amortization: 14463000
Net tangible assets: 1843304000
Owner earnings: 25025000
Return on net tangible assets (%): 1.3576165407333787
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.37
P/E ratio: 63.08132535883355
Shares outstanding: 114037648
Book value: 1935460000
P/B ratio: 1.3769645633389478
Market cap (USD): 2665059833.76
Debt to equity: 0.05114443078131297
Current ratio: 16.119712215986354
Quick ratio: 16.119712215986354
Effective tax rate (%): 0.9843442392425237
Interest coverage ratio: 8.961199294532628
COGS to revenue (%): 26.419434035405093
SG&A to revenue (%): 23.072748417108155
Free cash flow (dilution-adjusted): 21777000
Buyback yield (%): 0
Retained earnings: -21406000
Receivables turnover: 0.781354118288472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.24425101562946913
FCF margin (%): 56.27858896498255
Rule of 40 score: 56.27858896498255
Financial ratios for CURB — quarterly report dated 2025-06-30
Total revenue: 41402000
Gross profit: 30765000
Operating income: 6570000
Net income: 10406000
Capital expenditures: 0
Operating cash flow: 34172000
Depreciation & amortization: 16039000
Net tangible assets: 1824932000
Owner earnings: 26445000
Return on net tangible assets (%): 1.4490950895704606
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.21
P/E ratio: 120.79245336131248
Shares outstanding: 114037648
Book value: 1928981000
P/B ratio: 1.3130124983501652
Market cap (USD): 2532776162.08
Debt to equity: 0.05136909072717668
Current ratio: 9.644593934383103
Quick ratio: 9.644593934383103
Effective tax rate (%): 0.6871540370299676
Interest coverage ratio: 3.7181663837011882
COGS to revenue (%): 25.69199555577025
SG&A to revenue (%): 19.699531423602725
Free cash flow (dilution-adjusted): 31100000
Buyback yield (%): 0
Retained earnings: -27948000
Receivables turnover: 0.5523138698790038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3157765724543818
FCF margin (%): 75.11714409931888
Revenue growth (%): 6.995735883189043
Rule of 40 score: 82.11287998250792
Financial ratios for CURB — quarterly report dated 2025-09-30
Total revenue: 48647000
Gross profit: 36007000
Operating income: 8965000
Net income: 9358000
Capital expenditures: 0
Operating cash flow: 39189000
Depreciation & amortization: 19777000
Net tangible assets: 1790643000
Owner earnings: 29135000
Return on net tangible assets (%): 1.6270691589557493
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.85
P/E ratio: 82.16456534986482
Shares outstanding: 114037648
Book value: 1923519000
P/B ratio: 1.2953979704905436
Market cap (USD): 2491722608.8
Debt to equity: 0.2061024611662271
Current ratio: 7.507763714368597
Quick ratio: 7.507763714368597
Effective tax rate (%): 0.4679855349925548
Interest coverage ratio: 2.2508159678634194
COGS to revenue (%): 25.983102760704668
SG&A to revenue (%): 14.934117211749953
Free cash flow (dilution-adjusted): 36088000
Buyback yield (%): 0
Retained earnings: -35534000
Receivables turnover: 0.884909229817732
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3767134368409353
FCF margin (%): 74.18340288198657
Revenue growth (%): 17.499154630211102
Rule of 40 score: 91.68255751219766
Financial ratios for CURB — quarterly report dated 2025-12-31
Total revenue: 54149000
Gross profit: 41704000
Operating income: 10002000
Net income: 9555000
Capital expenditures: 0
Operating cash flow: 25869000
Depreciation & amortization: 22129000
Net tangible assets: 1771680000
Owner earnings: 31684000
Return on net tangible assets (%): 1.7883590716156417
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.93
P/E ratio: 65.56714396930869
Shares outstanding: 114037648
Book value: 1913470000
P/B ratio: 1.3665661173888277
Market cap (USD): 2614883268.64
Debt to equity: 0.2211892530324489
Current ratio: 5.105508940542006
Quick ratio: 5.105508940542006
Effective tax rate (%): 0.8920236489990664
Interest coverage ratio: 1.7173763736263736
COGS to revenue (%): 22.982880570278304
SG&A to revenue (%): 17.678996842046946
Free cash flow (dilution-adjusted): 22688000
Buyback yield (%): 0
Retained earnings: -46100000
Receivables turnover: 1.2314707420800073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4161592272969164
FCF margin (%): 41.89920404808953
Revenue growth (%): 11.310049951692807
Rule of 40 score: 53.209253999782334
Financial ratios for CURB — annual report dated 2025-12-31
Total revenue: 182893000
Gross profit: 136948000
Operating income: 30618000
Net income: 39881000
Capital expenditures: 0
Operating cash flow: 124601000
Depreciation & amortization: 72408000
Net tangible assets: 1771680000
Owner earnings: 112289000
Return on net tangible assets (%): 6.337995574821638
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.93
P/E ratio: 65.56714396930869
Shares outstanding: 114037648
Book value: 1913470000
P/B ratio: 1.3665661173888277
Market cap (USD): 2614883268.64
Debt to equity: 0.2211892530324489
Current ratio: 5.105508940542006
Quick ratio: 5.105508940542006
Effective tax rate (%): 0.763909624763611
Interest coverage ratio: 2.5218680504077096
COGS to revenue (%): 25.121245755715087
SG&A to revenue (%): 18.54745670966084
Free cash flow (dilution-adjusted): 111653000
Buyback yield (%): 0
Retained earnings: -46100000
Receivables turnover: 4.15940051397512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2739415338309326
FCF margin (%): 61.048263192139665
Revenue growth (%): 51.30003888121376
Rule of 40 score: 112.34830207335342
Financial ratios for CYRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.17
Shares outstanding: 50402313
Market cap (USD): 2982304860.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYRX — annual report dated 2022-12-31
Total revenue: 237277000
Gross profit: 103873000
Operating income: -31904000
Net income: -37333000
Capital expenditures: 22107000
Operating cash flow: -1851000
Depreciation & amortization: 22765000
Net tangible assets: 213712000
Owner earnings: -36675000
Return on net tangible assets (%): -17.16094557161039
Buffett classification: The Gruesome
Stock price: 17.35
Shares outstanding: 50402313
Book value: 555838000
P/B ratio: 1.5732643873754584
Market cap (USD): 874480130.5500001
Debt to equity: 0.7842356945728791
Current ratio: 14.78974810898142
Quick ratio: 14.112212675332305
Interest coverage ratio: -5.194399218495604
COGS to revenue (%): 56.222895603029365
R&D to revenue (%): 6.626010949228117
SG&A to revenue (%): 50.59698158692162
Free cash flow (dilution-adjusted): -46130000
Buyback yield (%): 4.340864780555418
Retained earnings: -542832000
Inventory turnover: 4.819856926078474
Receivables turnover: 5.41011902047517
Capitalized R&D asset: 15722000
ROCI (R&D-adjusted, %): -2.1134873099668483
FCF margin (%): -19.4414123577085
Rule of 40 score: -19.4414123577085
Financial ratios for CYRX — annual report dated 2023-12-31
Total revenue: 168662000
Gross profit: 75333000
Operating income: -50968000
Net income: -99587000
Capital expenditures: 38785000
Operating cash flow: -757000
Depreciation & amortization: 27487000
Net tangible assets: 186238000
Owner earnings: -110885000
Return on net tangible assets (%): -59.53940656579216
Buffett classification: The Gruesome
Stock price: 15.49
Shares outstanding: 50402313
Book value: 489023000
P/B ratio: 1.5965135144359264
Market cap (USD): 780731828.37
Debt to equity: 0.8506818697689066
Current ratio: 11.732339399254549
Quick ratio: 11.157772418329314
Interest coverage ratio: -9.134050179211469
COGS to revenue (%): 55.33493021546051
R&D to revenue (%): 10.695948109236223
SG&A to revenue (%): 64.18813959279505
Free cash flow (dilution-adjusted): -68465000
Buyback yield (%): 0
Retained earnings: -642419000
Inventory turnover: 3.561359993894528
Receivables turnover: 4.008698958977041
Capitalized R&D asset: 28573740
ROCI (R&D-adjusted, %): -4.696676568218733
Rosenberg metric: -1.8152906754865794
FCF margin (%): -40.593020360247124
Revenue growth (%): -28.91767849391218
Rule of 40 score: -69.5106988541593
Financial ratios for CYRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.11
Shares outstanding: 50402313
Market cap (USD): 408762758.42999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 50402313
Market cap (USD): 392129995.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYRX — annual report dated 2024-12-31
Total revenue: 156769000
Gross profit: 69657000
Operating income: -57862000
Net income: -114756000
Capital expenditures: 17254000
Operating cash flow: -16323000
Depreciation & amortization: 30757000
Net tangible assets: 233402000
Owner earnings: -101253000
Return on net tangible assets (%): -43.38137633782058
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 50402313
Book value: 401898000
P/B ratio: 0.9756953135870295
Market cap (USD): 392129995.14
Debt to equity: 0.6034839685691394
Current ratio: 5.29050694670322
Quick ratio: 4.957870607004011
Interest coverage ratio: -14.549157656525018
COGS to revenue (%): 55.56710829309366
R&D to revenue (%): 11.296876295696215
SG&A to revenue (%): 70.04509820181286
Free cash flow (dilution-adjusted): -57294000
Buyback yield (%): 0
Retained earnings: -757175000
Inventory turnover: 4.0562488359098525
Receivables turnover: 6.19542364843503
Capitalized R&D asset: 34985060
ROCI (R&D-adjusted, %): -8.503952764145229
Rosenberg metric: -0.3146341463414634
FCF margin (%): -36.54676626118684
Revenue growth (%): -7.051380868245366
Rule of 40 score: -43.598147129432206
Financial ratios for CYRX — quarterly report dated 2025-03-31
Total revenue: 41040000
Gross profit: 18641000
Operating income: -7194000
Net income: -11981000
Capital expenditures: 3168000
Operating cash flow: -4342000
Depreciation & amortization: 7646000
Net tangible assets: 232437000
Owner earnings: -7503000
Return on net tangible assets (%): -3.227971450328476
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 50402313
Book value: 398811000
P/B ratio: 0.7683992242942145
Market cap (USD): 306446063.04
Debt to equity: 0.6084787029445026
Current ratio: 5.555531541267054
Quick ratio: 5.240253951100905
Interest coverage ratio: -12.339622641509434
COGS to revenue (%): 54.57846003898636
R&D to revenue (%): 9.585769980506823
SG&A to revenue (%): 53.3650097465887
Free cash flow (dilution-adjusted): -12120000
Buyback yield (%): 0
Retained earnings: -769156000
Inventory turnover: 0.9596829477292202
Receivables turnover: 1.4465475309294702
Capitalized R&D asset: 3934000
ROCI (R&D-adjusted, %): -0.725898825138521
FCF margin (%): -29.53216374269006
Rule of 40 score: -29.53216374269006
Financial ratios for CYRX — quarterly report dated 2025-06-30
Total revenue: 45454000
Gross profit: 21377000
Operating income: -9649000
Net income: 105180000
Capital expenditures: 4351000
Operating cash flow: -7345000
Depreciation & amortization: 7296000
Net tangible assets: 353088000
Owner earnings: 108125000
Return on net tangible assets (%): 30.622677632771435
Buffett classification: The Gruesome
Stock price: 7.46
P/E ratio: 4.034391516861769
Shares outstanding: 50402313
Book value: 515391000
P/B ratio: 0.7295456361868949
Market cap (USD): 376001254.98
Debt to equity: 0.4433973429881391
Current ratio: 16.2356960429865
Quick ratio: 15.471657434740788
Interest coverage ratio: -15.61326860841424
COGS to revenue (%): 52.97003564042768
R&D to revenue (%): 9.059708716504598
SG&A to revenue (%): 59.19831037972456
Free cash flow (dilution-adjusted): -15921000
Buyback yield (%): 0
Retained earnings: -668235000
Inventory turnover: 1.045235511178641
Receivables turnover: 1.3605315932832471
Capitalized R&D asset: 6753780
ROCI (R&D-adjusted, %): -1.094557248461884
Rosenberg metric: 0.6954753431621759
FCF margin (%): -35.026620319443836
Revenue growth (%): 10.755360623781677
Rule of 40 score: -24.27125969566216
Financial ratios for CYRX — quarterly report dated 2025-09-30
Total revenue: 44233000
Gross profit: 21325000
Operating income: -9932000
Net income: -6943000
Capital expenditures: 3453000
Operating cash flow: 2188000
Depreciation & amortization: 6415000
Net tangible assets: 349608000
Owner earnings: -3981000
Return on net tangible assets (%): -1.1387039198187685
Buffett classification: The Gruesome
Stock price: 9.48
P/E ratio: 5.539486264607679
Shares outstanding: 50402313
Book value: 513271000
P/B ratio: 0.9309193919781169
Market cap (USD): 477813927.24
Debt to equity: 0.44978188909952055
Current ratio: 15.767764805359525
Quick ratio: 15.009171029952194
Interest coverage ratio: -18.88212927756654
COGS to revenue (%): 51.7893880134741
R&D to revenue (%): 10.225397327786947
SG&A to revenue (%): 60.43903872674248
Free cash flow (dilution-adjusted): -4620000
Buyback yield (%): 0.7837779073607732
Retained earnings: -675235000
Inventory turnover: 0.9820800823115836
Receivables turnover: 1.2669129861946498
Capitalized R&D asset: 8580280
ROCI (R&D-adjusted, %): -1.2764140418059677
Rosenberg metric: -0.012627489072365225
FCF margin (%): -10.444690615603735
Revenue growth (%): -2.686232234786817
Rule of 40 score: -13.13092285039055
Financial ratios for CYRX — annual report dated 2025-12-31
Total revenue: 176177000
Gross profit: 83054000
Operating income: -36806000
Net income: 78301000
Capital expenditures: 16439000
Operating cash flow: -8580000
Depreciation & amortization: 27712000
Net tangible assets: 342156000
Owner earnings: 89574000
Return on net tangible assets (%): 26.179286641181214
Buffett classification: The Gruesome
Stock price: 9.6
P/E ratio: 6.179515010025415
Shares outstanding: 50402313
Book value: 502638000
P/B ratio: 0.962645491984291
Market cap (USD): 483862204.79999995
Debt to equity: 0.4590142408651952
Current ratio: 2.1741318065181856
Quick ratio: 2.068259229834991
Interest coverage ratio: -15.589157136806438
COGS to revenue (%): 52.85763748957015
R&D to revenue (%): 9.67265874660143
SG&A to revenue (%): 58.36119357237324
Free cash flow (dilution-adjusted): -39117000
Buyback yield (%): 2.0689774693474883
Retained earnings: -688884000
Inventory turnover: 4.015999654993962
Receivables turnover: 5.281243442549237
Capitalized R&D asset: 34859900
ROCI (R&D-adjusted, %): -6.432509014241495
Rosenberg metric: 0.7564652738565782
FCF margin (%): -22.203238788264077
Revenue growth (%): 12.379998596661329
Rule of 40 score: -9.823240191602748
Financial ratios for CYRX — quarterly report dated 2025-12-31
Total revenue: 45450000
Gross profit: 21711000
Operating income: -10031000
Net income: -11644000
Capital expenditures: 4944000
Operating cash flow: 919000
Depreciation & amortization: 6355000
Net tangible assets: 342156000
Owner earnings: -10233000
Return on net tangible assets (%): -2.9907410654789044
Buffett classification: The Gruesome
Stock price: 9.6
P/E ratio: 6.485045365356779
Shares outstanding: 50402313
Book value: 502638000
P/B ratio: 0.962645491984291
Market cap (USD): 483862204.79999995
Debt to equity: 0.4590142408651952
Current ratio: 2.1741318065181856
Quick ratio: 2.068259229834991
Interest coverage ratio: -15.821766561514195
COGS to revenue (%): 52.231023102310225
R&D to revenue (%): 9.826182618261827
SG&A to revenue (%): 60.01320132013201
Free cash flow (dilution-adjusted): -6456000
Buyback yield (%): 0.4147875118350223
Retained earnings: -688884000
Inventory turnover: 1.0237622908400896
Receivables turnover: 1.3624509127971463
Capitalized R&D asset: 8855350
ROCI (R&D-adjusted, %): -1.7904701173619457
Rosenberg metric: 0.0853415874419633
FCF margin (%): -14.204620462046206
Revenue growth (%): 2.7513394976601178
Rule of 40 score: -11.453280964386089
Financial ratios for DEEZR.PA — annual report dated 2022-12-31
Total revenue: 479998936.1702128
Gross profit: 69250000
Operating income: -177390425.5319149
Net income: -178406382.9787234
Capital expenditures: 3247872.3404255323
Operating cash flow: -51891489.36170213
Depreciation & amortization: 9340425.531914894
Net tangible assets: -213065957.44680852
Owner earnings: -172313829.78723404
Buffett classification: The Gruesome
Stock price: 3.1063829787234045
Shares outstanding: 123868865
Book value: -193426595.74468088
Market cap (USD): 384784133.82978725
Debt to equity: -0.27139879331870354
Current ratio: 0.4944911708541635
Quick ratio: 0.4944911708541635
Interest coverage ratio: -183.03732162458834
COGS to revenue (%): 85.57266305998019
R&D to revenue (%): 7.541018486299836
SG&A to revenue (%): 29.637920296809167
Free cash flow (dilution-adjusted): -149006382.9787234
Buyback yield (%): 0.10782503241279916
Retained earnings: -712291489.3617022
Receivables turnover: 14.730142665926676
Capitalized R&D asset: 36196808.5106383
FCF margin (%): -31.043065255020508
Rule of 40 score: -31.043065255020508
Financial ratios for DEEZR.PA — annual report dated 2023-12-31
Total revenue: 538505555.5555556
Gross profit: 101592222.22222222
Operating income: -71566666.66666667
Net income: -64073333.33333333
Capital expenditures: 2327777.7777777775
Operating cash flow: -44437777.777777776
Depreciation & amortization: 18132222.22222222
Net tangible assets: -260742222.2222222
Owner earnings: -48268888.88888888
Buffett classification: The Gruesome
Stock price: 2.3666666666666667
Shares outstanding: 123868865
Book value: -251091111.1111111
Market cap (USD): 293156313.8333333
Debt to equity: -0.17950544733651355
Current ratio: 0.40806441724060416
Quick ratio: 0.40806441724060416
Interest coverage ratio: -72.45219347581553
COGS to revenue (%): 81.13462153490626
R&D to revenue (%): 7.16200183635782
SG&A to revenue (%): 12.316183677048622
Free cash flow (dilution-adjusted): -65618888.88888888
Buyback yield (%): 0.016676730666180858
Retained earnings: -790827777.7777778
Receivables turnover: 10.545606858435965
Capitalized R&D asset: 62819639.47990544
Rosenberg metric: 0.8935103273736632
FCF margin (%): -12.185368973806106
Revenue growth (%): 12.18890605303252
Rule of 40 score: 0.003537079226413553
Financial ratios for DEEZR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -259781250
Buffett classification: The Gruesome
Stock price: 1.3958333333333335
Shares outstanding: 123868865
Book value: -251522916.6666667
Market cap (USD): 172900290.7291667
Debt to equity: -0.13298987004166285
Current ratio: 0.3740057581241289
Quick ratio: 0.3740057581241289
Buyback yield (%): 0
Retained earnings: -756561458.3333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEEZR.PA — annual report dated 2024-12-31
Total revenue: 564287500
Gross profit: 128717708.33333334
Operating income: -28622916.666666668
Net income: -26967708.333333336
Capital expenditures: 1889583.3333333335
Operating cash flow: 15225000
Depreciation & amortization: 7738541.666666667
Net tangible assets: -259781250
Owner earnings: -21118750
Buffett classification: The Gruesome
Stock price: 1.3958333333333335
Shares outstanding: 123868865
Book value: -251522916.6666667
Market cap (USD): 172900290.7291667
Debt to equity: -0.13298987004166285
Current ratio: 0.3740057581241289
Quick ratio: 0.3740057581241289
Interest coverage ratio: -38.16388888888889
COGS to revenue (%): 77.18915446470106
R&D to revenue (%): 5.639117175789528
SG&A to revenue (%): 12.864859077450177
Free cash flow (dilution-adjusted): 5106250.000000001
Buyback yield (%): 0
Retained earnings: -756561458.3333334
Receivables turnover: 13.590125686761496
Capitalized R&D asset: 69606191.25295508
Rosenberg metric: 0.7033199129958805
FCF margin (%): 0.9049021996765834
Revenue growth (%): 4.787684022655285
Rule of 40 score: 5.692586222331869
Financial ratios for DEEZR.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -301935294.11764705
Buffett classification: The Gruesome
Stock price: 1.4588235294117646
Shares outstanding: 123868865
Book value: -292687058.8235295
Market cap (USD): 180702814.8235294
Debt to equity: -0.10693211782108172
Current ratio: 0.36279854527249666
Quick ratio: 0.36279854527249666
Buyback yield (%): 0
Retained earnings: -862811764.7058824
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DOMH — annual report dated 2021-12-31
Capital expenditures: 617000
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 22613781
Market cap (USD): 175935216.18
Buyback yield (%): 0
Capitalized R&D asset: 1707000
Rule of 40 score: 0
Financial ratios for DOMH — annual report dated 2022-12-31
Total revenue: 0
Operating income: -14346000
Net income: -22107000
Capital expenditures: 0
Operating cash flow: -10597000
Depreciation & amortization: -188000
Net tangible assets: 73767000
Owner earnings: -22295000
Return on net tangible assets (%): -30.223541692084538
Buffett classification: The Gruesome
Stock price: 2.54
Shares outstanding: 22613781
Book value: 73767000
P/B ratio: 0.7786544625645614
Market cap (USD): 57439003.74
Debt to equity: 0.010329822278254503
Current ratio: 28.31525992174399
Quick ratio: 28.31525992174399
Free cash flow (dilution-adjusted): -13902000
Buyback yield (%): 43.670673874400315
Retained earnings: -185881000
Receivables turnover: 0
Capitalized R&D asset: 3806690
ROCI (R&D-adjusted, %): -16.791114472258965
Rule of 40 score: 0
Financial ratios for DOMH — annual report dated 2023-12-31
Total revenue: 2039000
Operating income: -21796000
Net income: -22882000
Capital expenditures: 427000
Operating cash flow: -22232000
Depreciation & amortization: 442000
Net tangible assets: 52923000
Owner earnings: -22867000
Return on net tangible assets (%): -43.20805698845492
Buffett classification: The Gruesome
Stock price: 2.01
Shares outstanding: 22613781
Book value: 52923000
P/B ratio: 0.8588647622016892
Market cap (USD): 45453699.809999995
Debt to equity: 0.06517015286359427
Current ratio: 17.512134411947727
Quick ratio: 17.512134411947727
COGS to revenue (%): 0
R&D to revenue (%): -0.14713094654242276
SG&A to revenue (%): 1169.1025012260911
Free cash flow (dilution-adjusted): -25636000
Buyback yield (%): 2.0658384332300628
Retained earnings: -208763000
Receivables turnover: 0.6418004406672962
Capitalized R&D asset: 2344520
ROCI (R&D-adjusted, %): -39.89100134395691
FCF margin (%): -1257.28298185385
Rule of 40 score: -1257.28298185385
Financial ratios for DOMH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.43
Shares outstanding: 22613781
Market cap (USD): 32337706.83
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0